Overall search

In affiliation with HIV.gov

Main navigation

Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us

English

Home
Guidelines
HIV Clinical Guidelines: Pediatric ARV
Capsid Inhibitors

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Search Guidelines

Guidelines search

Archived Guidelines (1)
Guidelines for Caring for People With HIV Displaced by Disasters (4)
HIV Clinical Guidelines: Adult and Adolescent ARV (18)
HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (34)
HIV Clinical Guidelines: Pediatric ARV (19)
HIV Clinical Guidelines: Pediatric Opportunistic Infections (29)
Perinatal HIV Clinical Guidelines (18)

Version:

Brief Full

What's New Panel Members Financial Disclosure Introduction Pregnancy and Postpartum HIV Testing and Identification of Perinatal and Postnatal HIV Exposure Infant Feeding for Individuals With HIV in the United States Diagnosis of HIV in Infants and Children Clinical and Laboratory Monitoring of Pediatric HIV Infection When to Initiate Antiretroviral Treatment in Children with HIV Infection

Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children with HIV

What Not to Start: Regimens Not Recommended for Initial Antiretroviral Therapy in Infants and Children

Antiretroviral Management of Infants With In Utero, Intrapartum, or Breastfeeding Exposure to HIV Special Considerations for Antiretroviral Therapy Use in Adolescents With HIV Adherence to Antiretroviral Therapy in Children and Adolescents With HIV

Overview

Central Nervous System Toxicity

Dyslipidemia

Gastrointestinal Effects

Hematologic Effects

Hepatic Events

Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus

Lactic Acidosis

Lipodystrophies and Weight Gain

Nephrotoxic Effects

Osteopenia and Osteoporosis

Rash and Hypersensitivity Reactions

Overview

Modifying Antiretroviral Regimens in Children With Sustained Virologic Suppression on Antiretroviral Therapy

Recognizing and Managing Antiretroviral Treatment Failure

Antiretroviral Treatment Interruption in Children With HIV

Overview

Abacavir

Emtricitabine

Lamivudine

Tenofovir AF

Tenofovir DF

Zidovudine

Doravirine

Efavirenz

Etravirine

Nevirapine

Rilpivirine

Atazanavir

Darunavir

Lopinavir/Ritonavir

Fostemsavir

Ibalizumab

Maraviroc

Lenacapavir

Bictegravir

Cabotegravir

Dolutegravir

Elvitegravir

Raltegravir

Cobicistat

Ritonavir

Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets or as a Co-packaged Formulation, by Drug Class

Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

Overview

Didanosine

Enfuvirtide

Fosamprenavir

Indinavir

Nelfinavir

Saquinavir

Stavudine

Tipranavir

Drug Abbreviations

General Terms

Study and Trial Names

Appendix C: CDC Pediatric HIV CD4 Cell Count/Percentage and HIV-Related Diseases Categorization Appendix D: Supplemental Information

Download Guidelines

CONNECT WITH US

Footer menu

Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
Sponsors
Nondiscrimination Notice
Accessibility
Disclaimers
Sitemap
Privacy Policy
HHS Vulnerability Disclosure

Provided in collaboration with NIH’s Office of AIDS Research.

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

Search Guidelines

Download Guidelines

Related Content